A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants - IM032-007
Updated: 21 November, 2019 | ClinicalTrials.gov
Print Friendly Summary
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: - Healthy Participant, as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations - Body mass index (BMI) of 18.0 kg/m^2 to 32.0 kg/m^2, inclusive, and body weight ≥ 50 kg, at screening - Women and men must agree to follow methods of contraception. Exclusion Criteria: - Any significant acute or chronic medical illness - History of recent infection - History of allergy to BMS-986322 or other compounds Other protocol-defined inclusion/exclusion criteria could apply.